ICU Medical Inc has a consensus price target of $115.5, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from Keybanc, Keybanc, and CL King on February 28, 2024, February 6, 2024, and December 14, 2023. With an average price target of $126.67 between Keybanc, Keybanc, and CL King, there's an implied 18.03% upside for ICU Medical Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
02/28/2024 | ICUI | Buy Now | ICU Medical | $107.32 | 26.72% | Keybanc | Brett Fishbin | $134 → $136 | Maintains | Overweight | Get Alert |
02/06/2024 | ICUI | Buy Now | ICU Medical | $107.32 | 24.86% | Keybanc | Brett Fishbin | → $134 | Initiates | → Overweight | Get Alert |
12/14/2023 | ICUI | Buy Now | ICU Medical | $107.32 | 2.5% | CL King | Kristen Stewart | → $110 | Initiates | → Buy | Get Alert |
05/09/2023 | ICUI | Buy Now | ICU Medical | $107.32 | 101.27% | Keybanc | Matthew Mishan | — | Maintains | Overweight | Get Alert |
11/08/2022 | ICUI | Buy Now | ICU Medical | $107.32 | — | Raymond James | Jayson Bedford | — | Downgrade | Outperform → Market Perform | Get Alert |
08/09/2022 | ICUI | Buy Now | ICU Medical | $107.32 | 77.04% | Raymond James | Jayson Bedford | $208 → $190 | Maintains | Outperform | Get Alert |
08/09/2022 | ICUI | Buy Now | ICU Medical | $107.32 | 109.65% | Keybanc | Matthew Mishan | $230 → $225 | Maintains | Overweight | Get Alert |
08/08/2022 | ICUI | Buy Now | ICU Medical | $107.32 | 93.81% | Raymond James | Jayson Bedford | $235 → $208 | Maintains | Outperform | Get Alert |
08/03/2022 | ICUI | Buy Now | ICU Medical | $107.32 | 114.31% | Keybanc | Matthew Mishan | $265 → $230 | Maintains | Overweight | Get Alert |
05/10/2022 | ICUI | Buy Now | ICU Medical | $107.32 | 146.93% | Keybanc | Matthew Mishan | $280 → $265 | Maintains | Overweight | Get Alert |
05/10/2022 | ICUI | Buy Now | ICU Medical | $107.32 | 118.97% | Raymond James | Jayson Bedford | $265 → $235 | Maintains | Outperform | Get Alert |
02/28/2022 | ICUI | Buy Now | ICU Medical | $107.32 | 146.93% | Raymond James | Jayson Bedford | $286 → $265 | Maintains | Outperform | Get Alert |
10/22/2021 | ICUI | Buy Now | ICU Medical | $107.32 | 160.9% | Keybanc | Matthew Mishan | — | Maintains | Overweight | Get Alert |
09/09/2021 | ICUI | Buy Now | ICU Medical | $107.32 | 166.49% | Raymond James | Jayson Bedford | — | Maintains | Outperform | Get Alert |
09/09/2021 | ICUI | Buy Now | ICU Medical | $107.32 | 181.4% | Keybanc | Matthew Mishan | — | Maintains | Overweight | Get Alert |
08/06/2021 | ICUI | Buy Now | ICU Medical | $107.32 | 109.65% | Keybanc | Matthew Mishan | — | Maintains | Overweight | Get Alert |
08/05/2021 | ICUI | Buy Now | ICU Medical | $107.32 | 104.99% | Raymond James | Jayson Bedford | — | Maintains | Outperform | Get Alert |
The latest price target for ICU Medical (NASDAQ: ICUI) was reported by Keybanc on February 28, 2024. The analyst firm set a price target for $136.00 expecting ICUI to rise to within 12 months (a possible 26.72% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for ICU Medical (NASDAQ: ICUI) was provided by Keybanc, and ICU Medical maintained their overweight rating.
There is no last upgrade for ICU Medical.
The last downgrade for ICU Medical Inc happened on November 8, 2022 when Raymond James changed their price target from N/A to N/A for ICU Medical Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ICU Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ICU Medical was filed on February 28, 2024 so you should expect the next rating to be made available sometime around February 28, 2025.
While ratings are subjective and will change, the latest ICU Medical (ICUI) rating was a maintained with a price target of $134.00 to $136.00. The current price ICU Medical (ICUI) is trading at is $107.32, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.